Radiology Business
Radiology Business serves as a valuable information hub designed to assist C-suite hospital executives, physician-practice leaders, and payor organization leaders in their strategic planning efforts. It was created to guide healthcare leaders through the complexities and possibilities of healthcare transformation. Through its extensive media network, Radiology Business offers healthcare executives crucial insights into the news, challenges, and trends that are influencing the healthcare landscape.
Outlet metrics
Global
#413384
United States
#145420
Health/Medicine
#1177
Articles
-
2 days ago |
radiologybusiness.com | Dave Fornell
With rapidly growing proliferation artificial intelligence in medical imaging, the American College of Radiology wants to see more transparency around how these algorithms work. Some AI can accurately diagnose diseases, but details on how that decision is made is often trapped in a black box and not easily explainable. The ACR supported a resolution at the American Medical Association House of Delegates 2025 meeting earlier this month.
-
5 days ago |
radiologybusiness.com | Dave Fornell
The American Society of Nuclear Cardiology (ASNC), in collaboration with the American Medical Association (AMA), is taking a firm stance against health insurance companies’ growing use of artificial intelligence (AI) to automate prior authorization denials—an approach that physicians say is undermining patient care and contributing to professional burnout.
-
1 week ago |
radiologybusiness.com | Dave Fornell
A new resolution backed by the American College of Radiology is calling on the American Medical Association to increase national awareness and use of low-dose computed tomography for lung cancer screening and coronary calcium scoring. Radiology Business spoke with ACR CEO Dana Smetherman, MD, MBA, MPH, about the new policy in this video interview.
-
1 week ago |
radiologybusiness.com | Marty Stempniak
The American Medical Association passed a resolution at its recent annual meeting, urging for greater transparency in artificial intelligence use for radiology and other specialties. AMA wants to “maximize trust” among docs and the public around how these models reach their conclusions. It’s advocating for “explainable AI tools” that incorporate safety and efficiency data, with detailed explanations behind their output.
-
1 week ago |
radiologybusiness.com | Marty Stempniak
Bristol Myers Squibb is paying over $350 million to acquire the rights to a prostate cancer imaging agent and therapeutic, the pharmaceutical giant announced June 10. The company has inked a definitive deal to license the exclusive worldwide rights for the drug from Philochem, a Swiss biotechnology firm. Along with the nine-figure upfront payment, Bristol Myers Squibb will pay up to $1 billion more tied to developmental, regulatory and commercial milestones, along with eventual royalties.
Radiology Business journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://radiologybusiness.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →